Pierrel
ISIN: IT0004007560 | Ticker: PRL | LEI: 8156002BC7CB6E3BD403
Country: Italy
Pierrel is a global player in the pharmaceutical market, with over 70 years of experience in the field of oral care and listed at Euronext Milan of Borsa Italiana. Our legal and operational headquarters are in Capua, near Caserta and a few kilometers from Naples. The production facility received the first authorizations from the European Medicines Agency (EMA) in 1989 and from the Food and Drug Administration (FDA) in 2009 for the aseptic production of injectable drugs. Over the years, the core of our activity has been focused on the registration and marketing of dental anesthetics with Pierrel brand; including Orabloc, registered in the major international markets (including USA, Canada, Italy, Russia, Poland, Serbia, France, UK, Germany, Kosovo, Austria, Sudan, Taiwan and Indonesia). Today, thanks to the FDA’s approval, we have a significant market share in the USA and we have numerous registrations going on all over the world.
Year founded1948
HeadquartersStrada Statale Appia 7, 81043 Capua – Italy
| Line item in (eur) | 01.01.2020 | 01.01.2021 | 01.01.2022 |
|---|---|---|---|
| Cash and cash equivalents | 5,488,000.00 | 3,886,000.00 | 7,661,000.00 |
| Other Current Assets | N/A | 812,000.00 | 1,654,000.00 |
| Other Noncurrent Liabilities | N/A | 1,469,000.00 | 2,229,000.00 |
| Other Current Liabilities | N/A | 4,691,000.00 | 3,433,000.00 |
| Line item in (eur) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
|---|---|---|
| Services Expense | 2,944,000.00 | 3,137,000.00 |
| Profit (loss) | 1,903,000.00 | 2,940,000.00 |
| Line item in (eur) | 01.01.2020 | 01.01.2021 | 01.01.2022 |
|---|---|---|---|
| Profit (loss) | N/A | 1,903,000.00 | 2,940,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | -1,606,000.00 | 3,748,000.00 |
| Cash and cash equivalents | 5,488,000.00 | 3,886,000.00 | 7,661,000.00 |
Please note that some sums might not add up.
IT0004007560
LEI8156002BC7CB6E3BD403
SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.